ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth

Equity

ICICI Mutual Fund

Sector - Healthcare

Get the latest NAV of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.

₹39.75

▲1.1%1D

NAV as on 12 May 2025

22.38%/per year

Since Inception

Absolute Gain%

▲▼

6047 people have invested ₹ 4.3Cr in ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth in the last three months

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Performance vs. Nifty 500

Fund returns vs Benchmark returns vs Category Average returns as on (12-May-25)

The fund has consistently outperformed the benchmark (Nifty 500) over the last 1Y, 3Y, 5Y time periods.

Period
This Fund
Nifty 500
Category Avg
1 Month
4.63%
8.47%
3.21%
3 Months
2.55%
7.67%
1.68%
6 Months
-2.62%
0.81%
-3.86%
1 Year
23.79%
9.98%
18.38%
3 Years
28.39%
18.69%
22.56%
5 Years
26.3%
24.52%
21.85%

INDmoney Rank

Powered by IND quant engine

IND ranking is not available for this fund.

Fund Name
INDmoney Rank
AUM (in Crs.)
Expense Ratio
1Y Returns
3Y Returns
Inception Returns
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund
3/8
4,915Cr
1.18%
23.79%
28.39%
22.38%
SBI Healthcare Opportunities Fund Direct Growth
1/8
3,671Cr
0.9%
22.79%
27.26%
18.13%
DSP Healthcare Fund Direct Growth
4/8
2,912Cr
0.63%
13.42%
23.16%
23.88%
Mirae Asset Healthcare Fund Direct Growth
5/8
2,667Cr
0.52%
19.35%
23.27%
22.1%
See all
img
5Y returns in the top 25% of the category
img
3Y returns in the top 25% of the category
img
Larger AUM within category
img
No bad points found for this fund.

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Returns Calculator

Calculate SIP and lumpsum returns based on historical performance

  • 1-time

  • SIP

Total Investment

0

Profit

Total Corpus

0

Absolute Return
▲
▼

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Asset Allocation

as on (31-Mar-25)

Fund Distribution

as on (31-Mar-25)

Equity 98.3%

Debt & Cash 1.7%

Large cap
42.6%
Small cap
29.2%
Mid cap
26.3%
Mid Cap allocation has gone up from 25% to 26.3%
Mid Cap allocation has gone up from 25% to 26.3%
Large Cap allocation has gone down from 43.8% to 42.6%
Large Cap allocation has gone down from 43.8% to 42.6%
Small Cap allocation has gone down from 29.9% to 29.2%
Small Cap allocation has gone down from 29.9% to 29.2%
Cash allocation has gone up from 1% to 1.7%
Cash allocation has gone up from 1% to 1.7%

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Sector Allocation

as on (31-Mar-25)

Sector Allocation

Equity 98.3%

Debt & Cash 1.7%

Health
96.3%
Financial Services
2.5%
Basic Materials
1.2%

Top 3 Sectors in March were Health, Basic Materials & Financial Services

Mar'25

Health

91%

Basic Materials

6%

Financial Services

3%

Feb'25

Health

91%

Basic Materials

6%

Financial Services

3%

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Holdings Details

as on (30-Apr-25)

Equity

Top Stocks bought last month
Mankind Pharma Ltd's allocation increased from 2.85% to 3.5%
Mankind Pharma Ltd's allocation increased from 2.85% to 3.5%
Windlas Biotech Ltd's allocation increased from 1.42% to 1.82%
Windlas Biotech Ltd's allocation increased from 1.42% to 1.82%
Sun Pharmaceuticals Industries Ltd's allocation increased from 13.21% to 13.5%
Sun Pharmaceuticals Industries Ltd's allocation increased from 13.21% to 13.5%
Top Stocks sold last month
Cipla Ltd's allocation decreased from 9.55 % to 8.85 %
Cipla Ltd's allocation decreased from 9.55 % to 8.85 %
Divi's Laboratories Ltd's allocation decreased from 6.78 % to 6.71 %
Divi's Laboratories Ltd's allocation decreased from 6.78 % to 6.71 %
Lupin Ltd's allocation decreased from 4.73 % to 4.73 %
Lupin Ltd's allocation decreased from 4.73 % to 4.73 %

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth Overview

Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.

Expense ratio1.18%
Benchmark
BSE Healthcare TR INR
AUM₹4915 Cr
Inception Date12 July, 2018
Min Lumpsum/SIP₹5000/₹100
Exit Load
1.0%
Lock InNo Lock-in
TurnOver
49.46%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

About ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth is an equity fund. This fund was started on 12 July, 2018. The fund is managed by Dharmesh Kakkad. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth has ₹4915 Cr worth of assets under management (AUM) as on Mar 2025 and is more than category average.
  2. The fund has an expense ratio 1.2.

Returns

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth has given a CAGR return of 22.38% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 23.79%, 28.39% and 26.30% respectively.

Holdings

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials, Financial Services. Its top holdings are Sun Pharmaceuticals Industries Ltd, Dr Reddy's Laboratories Ltd, Cipla Ltd, Divi's Laboratories Ltd, Aurobindo Pharma Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth

To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 100.00. ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth has no lock in period.

Fund Manager

Dharmesh Kakkad

Fund Manager of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth, since 2 May 2020

Learn more about ICICI Mutual Fund
Parameters
Mar'25
Feb'25
Jan'25
AUM
₹ 4.9K Cr
₹ 4.6K Cr
₹ 5.3K Cr
  • AUM of the fund stands at 4.9K Cr as of Mar'25
  • AUM increased by 303.2 Cr between Mar'25 and Feb'25

Most Popular Comparisons

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund

VS

Nippon India Pharma Fund Direct Growth

Frequently Asked Questions for ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth

What is the current NAV of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth?

The current NAV of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth is ₹39.75 as on 12-May-2025.

What are the average returns of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth?

Existing (Absolute + CAGR) as on 12-May-2025.
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
4.63%
4.63%
6 Month Returns
-2.62%
-2.62%
1 Year Returns
23.79%
23.79%
3 Years Returns
111.66%
28.39%

How do I invest in ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth?

With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.

What is the expense ratio of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth?

1.18% as on April 2025

What is net assets under management (AUM) of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth?

₹4915 Cr as on April 2025

What are the top 5 holdings of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth?

Sun Pharmaceuticals Industries Ltd(13.5%), Dr Reddy's Laboratories Ltd(8.95%), Cipla Ltd(8.85%), Divi's Laboratories Ltd(6.71%), Aurobindo Pharma Ltd(5.3%) as on April 2025

What are the top 3 sectors that this ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth has invested in?

Health(89.38%), Basic Materials(5.98%), Financial Services(2.92%) as on April 2025

What is the alpha of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth?

The alpha ratio for the ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
2.31
4.56
3.59
As on April 2025
The alpha for ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth is calculated against BSE Healthcare TR INR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.

What is the beta of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth??

The Beta ratio for the ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
1
0.92
0.94
As on April 2025
The Beta for ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth is calculated with BSE Healthcare TR INR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.

What is the sharpe ratio of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth?

The sharpe ratio for the ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
0.78
1.09
1.22
As on April 2025
The sharpe ratio for ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth is calculated with BSE Healthcare TR INR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.

What is the standard deviation of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth?

The standard deviation for the ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
20.25
16.17
16.16
As on April 2025
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.

What is the Sortino ratio of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth?

Sortino ratio is 1.98 as on April 2025. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.

What is the information ratio of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth?

Information ratio is 1.44 as on April 2025. It tells the consistency of the fund in generating superior risk-adjusted performance

Who is the manager of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth?

Dharmesh Kakkad is the fund manager of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth

What is the exit load of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth?

The Exit load of ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth is 1%